Peritoneal Dialysis-Related Peritonitis due to Coagulase-Negative Staphylococcus: A Review of 115 Cases in a Brazilian Center

被引:32
作者
Camargo, Carlos Henrique [1 ,2 ]
Ribeiro de Souza da Cunha, Maria de Lourdes [2 ]
Teixeira Caramori, Jacqueline Costa [1 ]
Mondelli, Alessandro Lia [1 ]
Montelli, Augusto Cezar [1 ]
Barretti, Pasqual [1 ]
机构
[1] Sao Paulo State Univ Botucatu, Botucatu Med Sch, Dept Internal Med, BR-18618970 Sao Paulo, Brazil
[2] Sao Paulo State Univ Botucatu, Biosci Inst Botucatu, Dept Microbiol & Immunol, BR-18618970 Sao Paulo, Brazil
来源
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2014年 / 9卷 / 06期
关键词
FLIGHT MASS-SPECTROMETRY; INFECTIONS RECOMMENDATIONS; PATIENTS PREDICTORS; AUREUS PERITONITIS; IDENTIFICATION; STRAINS; EXPERIENCE; RESISTANCE; OUTCOMES; GENES;
D O I
10.2215/CJN.09280913
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background and objectives Coagulase-negative Staphylococcus (CNS) is the most frequent cause of peritoneal dialysis (PD) related peritonitis in many centers. This study aimed to describe clinical and microbiologic characteristics of 115 CNS episodes and to determine factors influencing the outcome. Design, setting, participants, & measurements This study reviewed the records of 115 CNS peritonitis episodes that occurred in 74 patients between 1994 and 2011 at a single university center. Peritonitis incidences were calculated for three consecutive 6-year periods (P1, 1994-1999; P2,2000-2005; P3,2006-2011) and annually. The production of biofilms, enzymes, and toxins was evaluated. Oxacillin resistance was evaluated based on its minimum inhibitory concentration and the presence of the mecA gene. Results The overall incidence of CNS peritonitis was 0.15 episodes per patient per year and did not vary over time (0.12, 0.14, and 0.16 for P1, P2, and P3, respectively; P=0.21). The oxacillin resistance rate was 69.6%. Toxin and enzyme production was infrequent and 36.5% of CNS strains presented the gene encoding biofilm production. The presence of icaAD genes associated with biofilm production was predictive of relapses or repeat episodes (odds ratio [On 2.82; 95% confidence interval [95% CI], 1.11 to 7.19; P=0.03). Overall, 70 episodes (60.9%) resolved; oxacillin susceptibility (OR, 4.41; 95% CI, 1.48 to 13.17; P=0.01) and vancomycin use as the first treatment (OR, 22.27; 95% CI, 6.16 to 80.53; P<0.001) were the only independent predictors of resolution. Conclusions Oxacillin resistance and vancomycin use as the first treatment strongly influence the resolution rate in CNS peritonitis, which reinforces the validity of the International Society for Peritoneal Dialysis guidelines on monitoring bacterial resistance to define protocols for initial treatment. These results also suggest that the presence of biofilm is a potential cause of repeat peritonitis episodes.
引用
收藏
页码:1074 / 1081
页数:8
相关论文
共 41 条
  • [1] [Anonymous], 2012, METHODS DILUTION ANT
  • [2] [Anonymous], 2013, PERF STAND ANT SUSC
  • [3] Presence of icaA and icaD genes and slime production in a collection of staphylococcal strains from catheter-associated infections
    Arciola, CR
    Baldassarri, L
    Montanaro, L
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (06) : 2151 - 2156
  • [4] Peritoneal Dialysis-Related Peritonitis Due to Staphylococcus aureus: A Single-Center Experience over 15 Years
    Barretti, Pasqual
    Moraes, Taise M. C.
    Camargo, Carlos H.
    Caramori, Jacqueline C. T.
    Mondelli, Alessandro L.
    Montelli, Augusto C.
    da Cunha, Maria de Lourdes R. S.
    [J]. PLOS ONE, 2012, 7 (02):
  • [5] Caramori JCT, 2011, THESIS SAO PAULO STA
  • [6] Comparison of the identification of coagulase-negative staphylococci by matrix-assisted laser desorption ionization time-of-flight mass spectrometry and tuf sequencing
    Carpaij, N.
    Willems, R. J. L.
    Bonten, M. J. M.
    Fluit, A. C.
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2011, 30 (10) : 1169 - 1172
  • [7] Identification of clinical staphylococcal isolates from humans by internal transcribed spacer PCR
    Couto, I
    Pereira, S
    Miragaia, M
    Sanches, IS
    de Lencastre, H
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (09) : 3099 - 3103
  • [8] Cunha MLRS, 2004, MEM I OSWALDO CRUZ, V99, P855, DOI 10.1590/S0074-02762004000800012
  • [9] da Cunha MDRS, 2007, MICROBIOL IMMUNOL, V51, P381, DOI 10.1111/j.1348-0421.2007.tb03925.x
  • [10] da Cunha MDRD, 2004, PERITON DIALYSIS INT, V24, P191